Key result
Increasing TG concentrations linked to extensive proatherogenic lipoprotein alterations in REDUCE-IT-like secondary prevention patients.
Why the study?
Elevated TG levels contribute to lipoprotein metabolism disruptions undetectable by standard lipid measures, prompting retrospective 1H-NMR spectroscopy analysis in secondary prevention patients resembling the REDUCE-IT population.
Observational (n=100)
In a REDUCE-IT-like secondary prevention cohort, 1H-NMR spectroscopy identified widespread proatherogenic lipoprotein alterations associated with elevated triglycerides that are undetectable by standard lipid panels.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open whether NMR-detected lipoprotein changes mediate residual risk in secondary prevention.
Background and aim Triglycerides (TG) are independent cardiovascular risk markers, yet TG-lowering therapies have failed to reduce major adverse cardiovascular events. However, high-dose icosapent ethyl (IPE) significantly reduces cardiovascular events in high-risk patients with controlled low-density lipoprotein cholesterol (LDL-C) and TG>1.7 mmol/L . Elevated TG levels contribute to widespread lipoprotein metabolism disruptions, which remain undetectable by standard lipid measures but can be characterized using proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy. This study retrospectively analyses lipoprotein alterations in secondary prevention patients with characteristics similar to those in REDUCE-IT, using 1 H-NMR spectroscopy (Liposcale® test). Methods and results Patients from our institutional databases who had undergone advanced lipoprotein and glycoprotein profiling by 1 H-NMR spectroscopy were included. Criteria required a history of major cardiovascular events, lipid-lowering therapy, LDL-C between 1.04-2.6 mmol/L, and TG 1.7-5.7 mmol/L. Lipoprotein particle number, size, and composition and glycoproteins A and B were analysed by nuclear magnetic resonance (NMR). A total of 100 patients (25% female, mean age 63 years, 39% with diabetes) were selected. The Liposcale test identified significant lipoprotein disturbances, including increased atherogenic small TG-rich remnant lipoproteins and small LDL particles, as well as elevated remnant cholesterol and TG enrichment in high-density lipoprotein. These abnormalities were associated to increasing TG concentrations. The results were visualized through lipid silhouette analysis. Conclusion In secondary prevention patients resembling the REDUCE-IT cohort, 1 H-NMR profiling revealed extensive proatherogenic lipoprotein alterations associated to increasing TG concentrations. Further research is underway to assess whether IPE mitigates these disturbances beyond its TG-lowering effects.
No takes yet. Share an insight, caveat, or question.
Masana et al. (2025) conducted an observational in Secondary prevention with elevated triglycerides (n=100). Elevated triglycerides was evaluated on Lipoprotein particle number, size, and composition and glycoproteins A and B. In secondary prevention patients resembling the REDUCE-IT cohort, 1H-NMR profiling revealed extensive proatherogenic lipoprotein alterations associated with increasing TG concentrations.
Synapse has enriched 10 related papers. Consider them for comparative context: